Hcw Biologics Inc (HCWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,960 | -8,679 | -4,125 | -2,197 | -30,024 |
| Depreciation Amortization | 1,042 | 885 | 711 | 419 | 1,184 |
| Accounts receivable | 550 | 552 | 561 | 495 | 954 |
| Other Working Capital | -2,782 | -2,420 | -2,207 | -2,162 | 13,603 |
| Other Operating Activity | -4,242 | -374 | -1,737 | -69 | 55 |
| Operating Cash Flow | $-13,392 | $-10,036 | $-6,796 | $-3,514 | $-14,227 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -262 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-262 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 150 | 150 | 150 | N/A | 6,905 |
| Debt Repayment | -128 | -95 | -63 | -33 | -119 |
| Common Stock Issued | 6,824 | 7,292 | 4,474 | 2 | 8,783 |
| Other Financing Activity | 3,823 | -888 | 0 | -22 | 0 |
| Financing Cash Flow | $10,670 | $6,458 | $4,561 | $-53 | $15,569 |
| Beginning Cash Position | 4,675 | 4,675 | 4,675 | 4,675 | 3,595 |
| End Cash Position | 1,953 | 1,097 | 2,439 | 1,108 | 4,675 |
| Net Cash Flow | $-2,722 | $-3,578 | $-2,236 | $-3,567 | $1,080 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,392 | -10,036 | -6,796 | -3,514 | -14,227 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -262 |
| Free Cash Flow | -13,392 | -10,036 | -6,796 | -3,514 | -14,489 |